Download Citation
Article Source:
Efficacy and safety of rimegepant 75 mg orally disintegrating tablet for the acute treatment of chronic rhinosinusitis in adults: Results from a multicenter, randomized, placebo-controlled, phase 2/3 trial
Franjic D,
Fountaine RJ,
Nalpas C,
Goswami B,
Fullerton T
(2026)
Efficacy and safety of rimegepant 75 mg orally disintegrating tablet for the acute treatment of chronic rhinosinusitis in adults: Results from a multicenter, randomized, placebo-controlled, phase 2/3 trial.
PLOS ONE 21(3): e0342907.
https://doi.org/10.1371/journal.pone.0342907